Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers.
Proteomics refers to the large-scale study of proteins, providing comprehensive and quantitative information on proteins in tissue, blood, and cell samples. In many studies, proteomics utilizes liquid chromatography-mass spectrometry. Proteomics has developed from a qualitative methodology of protein identification to a quantitative methodology for comparing protein expression, and it is currently classified into two distinct methodologies: quantitative and targeted proteomics. Quantitative proteomics comprehensively identifies proteins in samples, providing quantitative information on large-scale comparative profiles of protein expression. Targeted proteomics simultaneously quantifies only target proteins with high sensitivity and specificity. Therefore, in biomarker research, quantitative proteomics is used for the identification of biomarker candidates, and targeted proteomics is used for the validation of biomarkers. Understanding the specific characteristics of each method is important for conducting appropriate proteomics studies. In this review, we introduced the different characteristics and applications of quantitative and targeted proteomics, and then discussed the results of our recent proteomics studies that focused on the identification and validation of biomarkers of drug efficacy. These findings may enable us to predict the outcomes of cancer therapy and drug-drug interactions with antibiotics through changes in the intestinal microbiome.
['Masuda|Takeshi|T|', 'Mori|Ayano|A|', 'Ito|Shingo|S|', 'Ohtsuki|Sumio|S|']
D000818:Animals D015415:Biomarkers D000069196:Gastrointestinal Microbiome D006801:Humans D009369:Neoplasms D004364:Pharmaceutical Preparations D011506:Proteins D040901:Proteomics D015203:Reproducibility of Results D016896:Treatment Outcome
Biomarker Targeted proteomics Quantitative proteomics Cancer Intestinal microbiome Personalized medicine Protein quantification